Altogether, we have demonstrated that ACC inhibition, by reducing DNL and increasing mitochondrial oxidation rates, may have therapeutic utility for the suppression of aggressive GBM tumor growth, and that this mechanism warrants further investigation as a potential cancer therapy. Here, ACACA is linked to neoplasm.